The 29 references in paper V. Arkhipov V., A. Sokolov V., T. Rodina A., D. Pozdnyakov L., Е. Sокоvа А., В. Архипов В., А. Соколов В., Т. Родина А., Д. Поздняков Л., Е. Сокова А. (2018) “Новые подходы к рациональной фармакотерапии невралгии тройничного нерва на основе методологии персонализированной медицины // New approaches to rationale pharmacotherapy of trigeminal neuralgia based on personalized medicine principles” / spz:neicon:vedomostincesmp:y:2015:i:1:p:16-20

1
Gusev EN, Belousov YuB, Geht AB, Bondareva IB, Sokolov AV, Tischenkova IF. Treatment of epilepsy: Rational dosing of anticonvulsants. St. Petersburg: Rech; 2000 (in Russian).
(check this in PDF content)
2
Karlov VA. Treatment of nervous diseases. Moscow: Meditsina; 2004 (in Russian).
(check this in PDF content)
3
Kukes VG, Berry D, eds. Therapeutic drug monitoring: a tool for personalized medicine. Methodical recommendations. Moscow: Mezhdunarodnaya assotsiatsiya klinicheskih farmakologov i farmatsevtov; 2013 (in Russian).
(check this in PDF content)
4
Megdyatov RS. Trigeminal neuralgia. Moscow: Meditsina; 1999 (in Russian).
(check this in PDF content)
5
Kukes VG, ed. Personalized Medicine: Clinical and pharmacological aspects. Moscow: Mezhdunarodnaya assotsiatsiya klinicheskih farmakologov i farmatsevtov; 2014 (in Russian).
(check this in PDF content)
6
Stepanchenko AV, Grechko VE, Neymatov EM. Cranial nerves in normal and pathological conditions. Moscow: MNPI; 2001 (in Russian).
(check this in PDF content)
7
Kukes VG, ed. Handbook of drugs that are metabolized in the human body. Moscow: Mezhdunarodnaya assotsiatsiya klinicheskih farmakologov i farmatsevtov; 2013 (in Russian).
(check this in PDF content)
8
Holodov LE, Yakovlev VP. Clinical pharmacokinetics. Moscow: Meditsina; 1985 (in Russian).
(check this in PDF content)
9
Pienimäki P, Hartikainen AL, Arvela P, Partanen T, Herva R, Pelkonen O, Vähäkangas K. Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood. Epilepsia 1995; 36(3): 241–8.
(check this in PDF content)
10
Larry A. Applied Clinical Pharmacokinetics. McGraw-Hill; 2008.
(check this in PDF content)
11
Hung CC, Chang WL, Ho JL, Tai JJ, Hsieh TJ, Huang HC, Hsieh YW, Liou HH. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. Pharmacogenomics 2012 Jan; 13(2): 159–69.
(check this in PDF content)
12
Serralheiro A, Alves G, Fortuna A, Rocha M, Falcão A. First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-transdihydroxy-10,11-dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2013; Apr 15: 925.
(check this in PDF content)
13
Sato J, Saitoh T, Notani K, Fukuda H, Kaneyama K, Segami N. Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; PMID 14716252.
(check this in PDF content)
14
Guo-qiang Chen, Xiao-song Wang, Lin Wang, Jia-ping Zheng. Arterial compression of nerve is the primary cause of trigeminal neuralgia. Neurol Sci. 2014; 35(1): 61–66.
(check this in PDF content)
15
Kukes VG, Grachev SV, Sychev DA, et al. Metabolism of drugs. Scientific basis of personalized medicine. M .: GEOTAR-Media; 2008 (in Russian).
(check this in PDF content)
16
USP Drug Information. Volume I: Drug Information for the Health Care Professional.24th ed. Bethesda: Greenwood Village Co; 2004.
(check this in PDF content)
17
Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommision on therapeutic drug monitoring, ILAE commission on therapeutic strategies. Epilepsia 2008; (49): 1239–76.
(check this in PDF content)
18
Rambeck B, May TW, Jürgens MU, Blankenhorn V, Jürges U, Korn-Merker E, Sälke-Kellermann A. Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge system. Ther Drug Monit. 1994; (16): 608–12.
(check this in PDF content)
19
Sánchez A, Garcia R, Abadin JA, Durán JA. Determination of free serum carbamazepine by protein precipitation with sulphosalicylic acid. Pharm Pharmacol Commun. 1999; (5): 435–438.
(check this in PDF content)
20
20. Lanças FM, Sozza MA, Queiroz ME. Simultaneous plasma lamotrigine analysis with carbamazepine, carbamazepine-10,11-epoxide, primidone, phenytoin, phenobarbital, and PEMA by micellar electrokinetic capillary chromatography (MECC). J Anal Toxicol 2003; (27): 304–308.
(check this in PDF content)
21
Romanyshyn LA, Wichmann JK, Kucharczyk N, Shumaker RC, Ward D, Sofia RD. Simultaneous determination of felbamate, primidone, Phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin and one phenytoin metabolite in human plasma by high-performance liquid chromatography. Ther Drug Monit. 1994; (16): 90–99.
(check this in PDF content)
22
Bhatti MM, Hanson GD, Schultz L. Simultaneous determination of phenytoin, carbamazepine, and 10,11-carbamazepine epoxide in human serum by high-performance liquid chromatography with ultra-violet detection. J R E F E R E N C E S Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, 8 Petrovsky Boulevard, Moscow, 127051, Russian Federation. Arkhipov VV. Head of Department of drug interactions and rational pharmacotherapy of Clinical Pharmacology Center. Doctor of Medical Sciences. Sokolov AV. Senior researcher of Department of drug interactions and rational pharmacotherapy of Clinical Pharmacology Center. Doctor of Medical Sciences. Rodina TA. Se
(check this in PDF content)
23
Queiroz ME, Silva SM, Carvalho D, Lancas FM. Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, Phenobarbital, and primidone in human plasma by SPME-GC-TSD. J Chromatogr Sci. 2002; 40: 219–23.
(check this in PDF content)
24
Yoshida T, Imai K, Motohashi S, Hamano S, Sato M. Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography. J Pharm Biomed Anal. 2006; (41): 1386–90.
(check this in PDF content)
25
Oh E, Ban E, Woo JS, Kim CK. Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography. Anal Bioanal Chem. 2006; (386): 1931–36.
(check this in PDF content)
26
Leite CE, Petersen GO, Lunardelli A, Thiesen FV. A high-performance liquid chromatography method for the determination of carbamazepine and carbamazepine-10,11-epoxide and its comparison with chemiluminescent immunoassay. Clin Chem Lab Med. 2009; (47): 458–63.
(check this in PDF content)
27
Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP, Hillaire-Buys D. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; (828): 80–90.
(check this in PDF content)
28
Subramanian M, Birnbaum AK, Remmel RP. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Ther Drug Monit. 2008; (30): 347–56.
(check this in PDF content)
29
Vuckovic D, de Lannoy I, Gien B, et alYang Y, Musteata FM, Shirey R, Sidisky L, Pawliszyn J. In vivo solid-phase microextration for single rodent pharmacokinetics studies of carbamazepine and carbamazepine-10, 11-epoxide in mice. J Chromatogr A 2010; (1218): 3367–75. Pharm Biomed Anal. 1998; (16): 1233–1240.
(check this in PDF content)